CASP3 and hepatocellular carcinoma: As shown in Fig. 1H, in comparison with positive control that CHX and Lexa combination treatment-induced caspase 3 cleavages, the other four inhibitors did not reverse the insensitivity of HCC cells to Lexa-induced apoptosis.